Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Cocrystal Pharma, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 34 | 33 | −1 |
| Shares | 14.4M | 14.2M | −152.0K (−1.1%) |
| Value | $7.90M | $5.83M | −$2.08M (−26.3%) |
New holders (6)
Institutions that held Cocrystal Pharma, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 14,845 | $6.00K | 0.00% |
| Goldman Sachs Group Inc | 12,747 | $5.00K | 0.00% |
| Two Sigma Securities, LLC | 12,768 | $5.00K | 0.00% |
| HRT Financial LP | 12,508 | $5.00K | 0.00% |
| Huntington National Bank | 833 | $0 | 0.00% |
| Royal Bank of Canada | 100 | $0 | 0.00% |
Sold out (7)
Institutions that held Cocrystal Pharma, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Raymond James Financial Services Advisors, Inc. | 24,243 | $13.0K |
| Susquehanna International Group, LLP | 16,129 | $9.00K |
| Virtu Financial LLC | 14,237 | $8.00K |
| Two Sigma Advisers, LP | 13,000 | $7.00K |
| Focused Wealth Management, Inc | 250 | $0 |
| FinTrust Capital Advisors, LLC | 270 | $0 |
| Quent Capital, LLC | 266 | $0 |